BriaCell Therapeutics (TSX-V: BCT) (OTCQB: BCTXF) is an
immuno-oncology focused clinical-stage biotechnology company developing a
proprietary targeted immunotherapy technology for advanced breast cancer. A
recent article discussing the company reads: “The results of two previous
proof-of-concept clinical trials produced encouraging results in patients with
advanced breast cancer. Most notably, one patient with breast cancer that had
spread to other sites (metastatic cancer) responded to Bria-IMT with a substantial
tumor shrinkage in multiple sites including the breast, the lung, soft tissues
and even the brain. Similar observations have been confirmed more recently in
additional patients, and BriaCell is developing BriaDX as a way to identify
those patients most likely to respond.”
To view the full article, visit http://ibn.fm/nDr2L
About BriaCell
BriaCell is an immuno-oncology focused biotechnology company
developing targeted and safe approaches for the management of cancer. BriaCell
is currently conducting a Phase I/IIa clinical trial of Bria-IMT™, its lead
candidate, in a combination study with pembrolizumab [Keytruda®; manufactured
by Merck & Co., Inc.] or ipilimumab [Yervoy®; manufactured by Bristol-Myers
Squibb Company]. The combination study is listed in ClinicalTrials.gov as
NCT03328026. BriaCell is developing Bria-OTS™, an off-the-shelf personalized
immunotherapy, for advanced breast cancer. Bria-OTS™ immunotherapy treatments
are personalized to match the patient without the need for personalized
manufacturing. Bria-OTS™, which is expected to cover over 90% of the patient
population, is designed to produce a potent and selective immune response
against the cancer of each patient while eliminating the time, expense, and
complex manufacturing logistics associated with other personalized
immunotherapies. For more information, visit the company’s website at www.BriaCell.com
About QualityStocksNewsBreaks
QualityStocksNewsBreaks provide
a rapid summary of corporate news that catch the attention of QualityStocks.
QualityStocksBreaks are designed to keep investors up to date on important and
breaking news in the small-cap and micro-cap markets. Spanning all industries,
including energy, entertainment, telecommunications, healthcare, retail and
more, these news breaks deliver opportunities the investment community may have
missed. Whether it is earnings results, mergers and acquisitions, or any other
market-moving news, our news breaks keep you in the know. QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment